• Researchers May Have Found Better Combo-treatment Route for Brain Cancer
  • Hitchhiking Antibodies Can Deliver Disease-Fighting Therapy 100 Times Faster to the Brain
  • New Approach to Harnessing TGF-Beta Opens Door for Immunotherapy Development
  • FDA Accepts Adaptimmune’s IND Application for 3rd SPEAR T-cell Therapy
  • Celyad Retains US Patent for CAR T-cell Therapy Following Anonymous Challenge
  • FDA to Speed Review of Tecentriq for Certain Advanced Urothelial Cancers
  • Aduro and Merck to Start Clinical Trial Assessing Immunotherapy Combo in Gastric Cancer
  • Attacking Glioblastoma by Combining Immune Checkpoint Inhibitors with Gene Therapy Looks Promising
  • Some Cancer Cells Hide Mutations to Impair Immune Recognition, Study Finds
  • CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports
  • Immunotherapy Based on Natural Killer Cells May Soon Begin Clinical Studies
  • New Artificial Cells Can Activate T-cells to Target Cancer, Researchers Say